What Is CBN?

Key Facts

• CBN (cannabinol) is a mildly psychoactive cannabinoid formed primarily through the oxidation and degradation of THC over time (Mahadevan et al., 2000).
• It binds weakly to CB1 receptors — roughly one-tenth the affinity of THC — and shows moderate affinity for CB2 receptors involved in immune modulation (Rhee et al., 1997).
• First isolated from cannabis resin in 1896 by Wood, Spivey, and Easterfield, making it the earliest cannabinoid identified by chemists.
• CBN appears in aged or improperly stored cannabis at concentrations typically below 1% by dry weight; fresh cannabis contains almost none.
• Available commercially as oils, tinctures, capsules, and gummies — often combined with CBD or melatonin and marketed for sleep.
• According to a 2021 survey-based study, 74.5% of CBN product users reported using it specifically for sleep (Corroon, 2021).
• Human clinical data remains extremely limited — most claims rest on preclinical or anecdotal evidence.

Commercial Disclosure

Azarius sells cannabinoid-related products and has a commercial interest in this topic. Our editorial process includes independent pharmacological review to mitigate commercial bias.

Health Disclaimer

This article is for informational purposes only and does not constitute medical advice. CBN is a pharmacologically active compound. Consult a qualified healthcare professional before using CBN, especially if you are pregnant, breastfeeding, taking prescription medication, or managing a chronic health condition. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) notes that minor cannabinoids like CBN remain under-researched, and consumers should exercise caution when interpreting marketing claims as clinical evidence.

Contraindications

CBN has sedative properties that interact with central nervous system depressants. Before looking at dosage or effects, here is who should avoid it entirely or proceed only under medical supervision:

• Pregnancy and breastfeeding: No safety data exists for CBN in pregnant or lactating individuals. The American College of Obstetricians and Gynecologists advises against all cannabis-derived compounds during pregnancy (ACOG, 2017).
• Sedative and benzodiazepine users: CBN may amplify drowsiness when combined with drugs like diazepam, zolpidem, or antihistamines that cause sedation (Corroon, 2021).
• Antihypertensive medication: CBN may lower blood pressure, increasing the risk of hypotension when stacked with blood-pressure-lowering drugs.
• Liver impairment: Like most cannabinoids, CBN is metabolised hepatically via cytochrome P450 enzymes. Compromised liver function may alter clearance rates unpredictably.
• Driving and machinery: Even at low doses, CBN can cause drowsiness. Do not drive or operate heavy equipment after taking it.
• Children and adolescents: No paediatric safety data exists. Keep all CBN products away from anyone under 18.

History and Origin

CBN is the first cannabinoid ever isolated from the cannabis plant, identified in 1896 by British chemists. Thomas Wood, W.T.N. Spivey, and Thomas Easterfield extracted a crystalline compound from Indian hemp resin and named it cannabinol (Wood et al., 1896). They had no idea what it did biologically — receptor pharmacology was still decades away. For the next forty years, researchers actually assumed CBN was the primary intoxicating agent in cannabis. That changed in 1964 when Raphael Mechoulam and Yechiel Gaoni identified delta-9-THC as the real psychoactive driver (Mechoulam & Gaoni, 1964), and CBN was quietly reclassified as a degradation product.

AZARIUS · History and Origin

The renewed interest in CBN is a 2010s phenomenon, driven almost entirely by the commercial cannabinoid boom. As CBD saturated the market, companies started looking for the next minor cannabinoid to differentiate their products. CBN, with its anecdotal reputation as a sleep aid, fit the brief perfectly — even though the evidence behind that reputation is thinner than most marketing copy suggests.

Chemistry and Active Compounds

CBN (C₂₁H₂₆O₂) is a tricyclic terpenophenolic compound with a molecular weight of 310.43 g/mol. It forms when THC loses hydrogen atoms through exposure to heat, light, and oxygen — a process called oxidative aromatisation. The cyclohexene ring in THC becomes fully aromatic in CBN, which is why CBN's psychoactivity drops so dramatically: the flat aromatic ring fits the CB1 receptor much less snugly.

AZARIUS · Chemistry and Active Compounds

Ki values sourced from Rhee et al. (1997). CBN also interacts with TRPV2 channels and TRPA1 receptors, which may be relevant to its reported analgesic and anti-inflammatory properties — though the exact contribution of each pathway in humans remains unclear, as most of this receptor work comes from cell-line and rodent studies, not human trials.

CBN vs CBD vs THC

CBN sits between CBD and THC in terms of psychoactivity, but its pharmacological profile is distinct from both. Understanding the differences helps you decide which cannabinoid — or combination — suits your purpose. For a deeper dive into CBD, see the Azarius wiki page on CBD. For THC specifics, the Azarius wiki on THC covers receptor binding and effects in detail.

• Psychoactivity: THC is strongly psychoactive, CBN is mildly psychoactive (roughly one-tenth of THC's CB1 affinity), and CBD is not psychoactive at all.
• Legal status: CBD derived from hemp is broadly legal across the EU. THC remains controlled in most jurisdictions. CBN occupies a grey area — it is not explicitly scheduled in many countries, but because it derives from THC, legal interpretations vary.
• Research depth: CBD has hundreds of clinical trials behind it, including FDA-approved use for epilepsy (Epidiolex). THC has decades of human data. CBN has almost none — a handful of small human studies and a growing body of preclinical work.
• Primary use case: Users typically buy CBD for anxiety and inflammation, THC for pain and recreation, and CBN for sleep — though CBN's sleep evidence is the weakest of the three.

Effects Overview

CBN is most commonly described as mildly sedating, though the degree to which it actually causes sleepiness on its own is debated. A frequently cited 1975 study by Musty et al. found that CBN enhanced the sedative effects of THC in human volunteers — but CBN alone did not produce significant sedation in that same study. The "CBN equals sleep" narrative may owe more to the entourage effect (CBN appearing alongside other sedating terpenes like myrcene in aged cannabis) than to CBN acting solo.

AZARIUS · Effects Overview

What users generally report: a gentle heaviness, mild muscle relaxation, and an easier time falling asleep. Nobody describes CBN as producing a noticeable altered state of consciousness at standard doses.

Dosage Guide

The most commonly used oral dose of CBN for sleep falls between 10 and 20 mg, based on commercial product norms and limited survey data. Human dosing data for CBN is sparse. The ranges below are compiled from published survey data (Corroon, 2021), product-label norms, and the limited clinical literature available. These are observed ranges, not recommendations.

CBN may intensify THC's psychoactive effects when taken together (Musty et al., 1975). If you are combining cannabinoids, the observed ranges above should be treated as upper bounds, not starting points.

Preparation Methods

Oils and tinctures

Sublingual oil is the most common CBN format and the easiest way to control your dose. CBN is dissolved in a carrier oil (MCT or hemp seed oil) and dosed sublingually via a dropper. Hold the oil under your tongue for 60 seconds before swallowing — sublingual absorption bypasses first-pass metabolism and gets the compound into your bloodstream faster than swallowing it straight. If you want to buy CBN oil, look for products with a third-party certificate of analysis (COA) that confirms the CBN content per millilitre.

Capsules and gummies

Pre-dosed and convenient, though onset is slower because everything passes through the digestive system first. Gummies often combine CBN with CBD or melatonin. Check the label for the CBN content per unit — some products list total cannabinoid content rather than CBN specifically, which can be misleading. Azarius stocks several CBN-containing sleep formulations in the cannabinoid product category.

Vaporisation

CBN isolate can be vaporised, though standalone CBN vape products are less common than oils. Vaporising gives the fastest onset but the shortest duration, making it less practical for sleep maintenance. Temperature matters: CBN's boiling point is approximately 185 degrees C (365 degrees F). For vaporiser options, see the Azarius vaporizer category.

Aged cannabis

The DIY route. Leaving THC-rich cannabis exposed to air and light for several months converts some THC to CBN naturally. This is uncontrolled and imprecise — you will not know the CBN concentration without lab testing — but it is how humans have been consuming CBN for centuries without knowing it.

How to Choose a CBN Product

The single most important factor when choosing a CBN product is third-party lab verification. The unregulated cannabinoid market means label accuracy varies wildly — a 2020 analysis found some products contained significantly more or less CBN than claimed (Corroon, 2021). Here is what to look for:

• Certificate of analysis (COA): A current COA from an independent lab should be available on the product page or by request. It should confirm CBN concentration, THC content (important for legality and drug testing), and absence of heavy metals, pesticides, and residual solvents.
• CBN per serving vs total: Some labels list total cannabinoid content for the entire bottle rather than per dose. Always check the per-serving figure.
• Carrier oil: MCT oil is the most common and well-absorbed. Hemp seed oil is also fine. Avoid products that do not specify the carrier.
• Combination formulas: Many sleep products combine CBN with CBD, melatonin, or terpenes like linalool and myrcene. These may be more effective than CBN alone, given the entourage effect hypothesis, but they also make it harder to attribute any benefit specifically to CBN.
• Extraction method: CO2 extraction is considered the cleanest. Ethanol extraction is also acceptable. Avoid products that do not disclose their extraction method.

Safety and Drug Interactions

CBN has no documented cases of life-threatening toxicity in humans, but the honest assessment is that we do not have enough human safety data to make confident statements about its full risk profile. Most of what we know comes from preclinical models and user surveys. A 2021 cross-sectional survey of CBN users found that the most commonly reported side effects were next-day drowsiness and mild dizziness (Corroon, 2021). No serious adverse events were documented in that survey, but the sample was self-selected and small.

Known and suspected side effects

• Drowsiness (the most consistently reported effect, which is also the intended one for sleep products)
• Dizziness and lightheadedness, particularly at higher doses
• Mild appetite stimulation — a 2012 rodent study observed increased food intake with CBN administration (Farrimond et al., 2012)
• Possible next-morning grogginess at doses above 20 mg

Drug interactions

CBN is metabolised by cytochrome P450 enzymes, particularly CYP2C19 and CYP3A4. Any drug processed by the same pathways could theoretically see altered blood levels when CBN is present. The interaction table below lists the most relevant categories, but this is not exhaustive — if you take prescription medication, talk to your prescriber before adding CBN.

Product quality is also a safety variable. Third-party certificates of analysis (COAs) from independent labs are the only way to verify what is actually in the bottle.

Research Status

CBN research is in its early stages — roughly where CBD research was in 2010. Most findings come from preclinical models, and the few human studies are small and dated.

Sleep

This is CBN's headline claim, and the evidence is thinner than the marketing suggests. The most cited human study (Musty et al., 1975) tested CBN in combination with THC and found enhanced sedation — but CBN alone did not produce statistically significant sedation compared to placebo in that same study. A 2021 survey found that users perceive CBN as helpful for sleep, with 74.5% reporting sleep as their primary reason for use (Corroon, 2021), but self-reported survey data cannot establish causation.

Pain and inflammation

A 2019 preclinical study in rats found that CBN reduced mechanical sensitisation (a proxy for pain) in a myofascial pain model, with effects comparable to CBD but through a different mechanism (Wong & Bhatt, 2019). CBN also showed anti-inflammatory activity in a rodent model of allergic airway inflammation (Russo, 2011). These are interesting signals, but rodent results frequently fail to translate to humans.

Neuroprotection

A 2005 study in a rodent model of amyotrophic lateral sclerosis (ALS) found that CBN delayed symptom onset by several weeks (Weydt et al., 2005). This is a single preclinical study and has not been replicated or tested in humans.

Antibacterial activity

CBN showed activity against methicillin-resistant Staphylococcus aureus (MRSA) strains in vitro (Appendino et al., 2008). Interesting in a petri dish; a long way from clinical application.

The pattern across all these areas is the same: promising preclinical signals, minimal to no human data. If you are interested in the broader field of cannabinoid research, the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) maintains an updated database of cannabinoid studies and regulatory developments across Europe.

Legal Status in Europe

CBN is not explicitly listed as a controlled substance in most European countries, but its legal status is complicated by its origin as a THC degradation product. In the Netherlands, CBN products derived from hemp containing less than 0.2% THC generally fall outside the Opium Act, though enforcement and interpretation can vary. Across the EU, the 2020 Court of Justice ruling on CBD (the Kanavape case) established that hemp-derived cannabinoids are not narcotics if they come from legally cultivated varieties — but this ruling addressed CBD specifically, and its applicability to CBN has not been tested in court. If you plan to buy CBN products and travel within Europe, check the specific regulations in your destination country. The Beckley Foundation has published useful overviews of cannabinoid regulation across European jurisdictions.

Emergency Information

CBN has not been associated with life-threatening toxicity in any published literature, but if you or someone else experiences severe drowsiness, confusion, difficulty breathing, or a significant drop in blood pressure after taking CBN (especially in combination with other sedatives), contact emergency services immediately.

• Netherlands: 112
• EU general emergency: 112
• UK: 111 (NHS non-emergency) or 999
• Poison control (NL): +31 30 274 8888 (NVIC)

Tell medical staff exactly what was taken, how much, and when. If you combined CBN with other substances, mention all of them.